08/09/2024 4:24 PM | Enanta Pharmaceuticals (Issuer) Rottinghaus Scott T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 3:00 PM | Enanta Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024 4:29 PM | Enanta Pharmaceuticals (Issuer) Rottinghaus Scott T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 4:30 PM | Enanta Pharmaceuticals (Subject) Rottinghaus Scott T. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 7:38 PM | Enanta Pharmaceuticals (Issuer) Kieffer Tara Lynn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:23 PM | Enanta Pharmaceuticals (Issuer) Peterson Kristine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:27 PM | Enanta Pharmaceuticals (Issuer) Russell Lesley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/08/2024 4:30 PM | Enanta Pharmaceuticals (Issuer) Vance Terry (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:15 PM | Enanta Pharmaceuticals (Issuer) FOLETTA MARK G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:19 PM | Enanta Pharmaceuticals (Issuer) Hata Yujiro S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:12 PM | CARTER BRUCE L A (Reporting) Enanta Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 5:31 PM | Enanta Pharmaceuticals (Issuer) Gardiner Nathaniel S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 12:11 PM | Enanta Pharmaceuticals (Subject) Krensavage Asset Management, LLC (Filed by)
| Form SCHEDULE 13G | |
02/14/2024 7:21 PM | Enanta Pharmaceuticals (Issuer) Kieffer Tara Lynn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:23 PM | Enanta Pharmaceuticals (Issuer) Luu Brendan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:00 PM | Enanta Pharmaceuticals (Issuer) Luly Jay R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:09 PM | Enanta Pharmaceuticals (Issuer) MELLETT PAUL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:12 PM | Enanta Pharmaceuticals (Issuer) Or Yat Sun (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:15 PM | Enanta Pharmaceuticals (Issuer) Rottinghaus Scott T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:18 PM | Enanta Pharmaceuticals (Issuer) Gardiner Nathaniel S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 1:26 PM | ARMISTICE CAPITAL, LLC (Filed by) Enanta Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024 11:15 PM | Enanta Pharmaceuticals (Filer)
| Form EFFECT | |
01/26/2024 8:11 AM | Enanta Pharmaceuticals (Subject) Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
01/24/2024 4:23 PM | BlackRock Inc. (Filed by) Enanta Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/22/2024 11:25 AM | Enanta Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/11/2024 3:15 PM | Enanta Pharmaceuticals (Subject) MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
12/15/2023 7:08 PM | Enanta Pharmaceuticals (Issuer) Vance Terry (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 4:16 PM | Enanta Pharmaceuticals (Subject) Vance Terry (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 7:26 PM | Enanta Pharmaceuticals (Issuer) Gardiner Nathaniel S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 7:29 PM | Enanta Pharmaceuticals (Issuer) Kieffer Tara Lynn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 7:31 PM | Enanta Pharmaceuticals (Issuer) Luu Brendan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 7:17 PM | Enanta Pharmaceuticals (Issuer) Luly Jay R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 7:19 PM | Enanta Pharmaceuticals (Issuer) MELLETT PAUL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 7:22 PM | Enanta Pharmaceuticals (Issuer) Or Yat Sun (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 7:24 PM | Enanta Pharmaceuticals (Issuer) Rottinghaus Scott T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 8:24 PM | Enanta Pharmaceuticals (Issuer) Luu Brendan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 8:08 PM | Enanta Pharmaceuticals (Issuer) Luly Jay R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 8:11 PM | Enanta Pharmaceuticals (Issuer) MELLETT PAUL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 8:15 PM | Enanta Pharmaceuticals (Issuer) Or Yat Sun (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 8:19 PM | Enanta Pharmaceuticals (Issuer) Gardiner Nathaniel S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 8:21 PM | Enanta Pharmaceuticals (Issuer) Kieffer Tara Lynn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
War on Elon Escalates… (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. |
11/22/2023 4:10 PM | Enanta Pharmaceuticals (Issuer) Luly Jay R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 4:10 PM | Enanta Pharmaceuticals (Issuer) Rottinghaus Scott T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 4:11 PM | Enanta Pharmaceuticals (Issuer) Or Yat Sun (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 4:11 PM | Enanta Pharmaceuticals (Issuer) Gardiner Nathaniel S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 4:12 PM | Enanta Pharmaceuticals (Issuer) MELLETT PAUL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 4:12 PM | Enanta Pharmaceuticals (Issuer) Kieffer Tara Lynn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 4:12 PM | Enanta Pharmaceuticals (Issuer) Luu Brendan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 3:38 PM | Enanta Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
11/22/2023 3:12 PM | Enanta Pharmaceuticals (Filer)
| Form POSASR | |
11/22/2023 3:21 PM | Enanta Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
11/16/2023 3:31 PM | Enanta Pharmaceuticals (Subject) MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
10/06/2023 1:34 PM | BlackRock Inc. (Filed by) Enanta Pharmaceuticals (Subject)
| Form SC 13G/A | |